Jailendra Singh
Stock Analyst at Truist Financial
(0.20)
# 4,600
Out of 5,010 analysts
788
Total ratings
43.6%
Success rate
-5.3%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Reiterated: Buy | n/a | $35.45 | - | 31 | Sep 29, 2026 | |
| AGL agilon health | Reiterated: Hold | n/a | $78.15 | - | 36 | Sep 28, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $300 → $329 | $268.99 | +22.31% | 48 | Sep 28, 2026 | |
| MDLN Medline | Reiterated: Buy | n/a | $34.98 | - | 9 | Sep 22, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | n/a | $170.35 | - | 37 | Sep 17, 2026 | |
| MEDP Medpace Holdings | Reiterated: Hold | n/a | $622.11 | - | 20 | Sep 17, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | n/a | $25.07 | - | 18 | Sep 16, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Hold | $32 | $28.70 | +11.50% | 62 | Sep 11, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Buy | n/a | $19.74 | - | 15 | Sep 3, 2026 | |
| PHR Phreesia | Reiterated: Hold | n/a | $10.01 | - | 27 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.75 | - | 65 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $278.57 | - | 38 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.23 | - | 42 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $13.14 | -8.68% | 38 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 | $26.52 | -9.50% | 30 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $24.79 | +45.22% | 47 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $19.62 | +68.20% | 39 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $6 | $3.52 | +70.45% | 53 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $112 | $95.21 | +17.63% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $35.34 | +18.85% | 1 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.24 | - | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.58 | - | 1 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $204.48 | -43.27% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.93 | n/a | 3 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.20 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.39 | n/a | 1 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $62.21 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $275.26 | n/a | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $392.73 | n/a | 1 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $47.75 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.18 | n/a | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $386.87 | n/a | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.78 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.24 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,184.63 | n/a | 1 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $431.63 | n/a | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $22 | $40.50 | n/a | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $610 | $374.94 | n/a | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $31 → $16 | $0.7189 | n/a | 19 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $43 | $0.612 | n/a | 12 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $24 | $0.93 | n/a | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $4 | $0.4274 | n/a | 9 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $62 | $223.91 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 → $3.5 | $4.33 | n/a | 4 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $180 | $307.60 | n/a | 14 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $230 → $333 | $864.82 | n/a | 12 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $21 | $29.77 | n/a | 4 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $176.45 | n/a | 1 | Feb 26, 2020 |
Astrana Health
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.45
Upside: -
agilon health
Sep 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $78.15
Upside: -
IQVIA Holdings
Sep 28, 2026
Reiterated: Buy
Price Target: $300 → $329
Current: $268.99
Upside: +22.31%
Medline
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.98
Upside: -
ICON Public Limited Company
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $170.35
Upside: -
Medpace Holdings
Sep 17, 2026
Reiterated: Hold
Price Target: n/a
Current: $622.11
Upside: -
Waystar Holding
Sep 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.07
Upside: -
Hims & Hers Health
Sep 11, 2026
Reiterated: Hold
Price Target: $32
Current: $28.70
Upside: +11.50%
Fortrea Holdings
Sep 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.74
Upside: -
Phreesia
Sep 3, 2026
Reiterated: Hold
Price Target: n/a
Current: $10.01
Upside: -
Sep 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.75
Upside: -
Aug 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $278.57
Upside: -
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.23
Upside: -
Aug 13, 2026
Reiterated: Hold
Price Target: $12
Current: $13.14
Upside: -8.68%
Aug 13, 2026
Reiterated: Hold
Price Target: $24
Current: $26.52
Upside: -9.50%
Aug 13, 2026
Reiterated: Buy
Price Target: $36
Current: $24.79
Upside: +45.22%
Aug 13, 2026
Reiterated: Buy
Price Target: $33
Current: $19.62
Upside: +68.20%
Aug 12, 2026
Rated: Hold
Price Target: $7 → $6
Current: $3.52
Upside: +70.45%
Aug 11, 2026
Rated: Buy
Price Target: $112
Current: $95.21
Upside: +17.63%
Aug 10, 2026
Reiterated: Buy
Price Target: $42
Current: $35.34
Upside: +18.85%
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.24
Upside: -
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.58
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: $116
Current: $204.48
Upside: -43.27%
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.93
Upside: n/a
Jul 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.20
Upside: n/a
Jul 17, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.39
Upside: n/a
Jul 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $62.21
Upside: n/a
May 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $275.26
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $392.73
Upside: n/a
Jan 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $47.75
Upside: n/a
Nov 19, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.18
Upside: n/a
Oct 3, 2024
Rated: Hold
Price Target: n/a
Current: $386.87
Upside: n/a
Sep 9, 2024
Reiterated: Hold
Price Target: n/a
Current: $12.78
Upside: n/a
Sep 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.24
Upside: n/a
Jul 3, 2024
Reiterated: Buy
Price Target: n/a
Current: $1,184.63
Upside: n/a
Apr 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $431.63
Upside: n/a
Apr 16, 2024
Reiterated: Hold
Price Target: $21 → $22
Current: $40.50
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $610
Current: $374.94
Upside: n/a
Mar 3, 2022
Reiterated: Hold
Price Target: $31 → $16
Current: $0.7189
Upside: n/a
Feb 28, 2022
Reiterated: Hold
Price Target: $42 → $43
Current: $0.612
Upside: n/a
Feb 24, 2022
Reiterated: Hold
Price Target: $30 → $24
Current: $0.93
Upside: n/a
Feb 8, 2022
Downgraded: Hold
Price Target: $14 → $4
Current: $0.4274
Upside: n/a
Jan 7, 2022
Reiterated: Hold
Price Target: $50 → $62
Current: $223.91
Upside: n/a
Jan 7, 2022
Downgraded: Sell
Price Target: $9 → $3.5
Current: $4.33
Upside: n/a
Jan 7, 2022
Reiterated: Buy
Price Target: $145 → $180
Current: $307.60
Upside: n/a
Jan 7, 2022
Upgraded: Buy
Price Target: $230 → $333
Current: $864.82
Upside: n/a
Nov 11, 2021
Reiterated: Buy
Price Target: $26 → $21
Current: $29.77
Upside: n/a
Feb 26, 2020
Reiterated: Buy
Price Target: $30
Current: $176.45
Upside: n/a